162–163 ◦C (from acetone). IR (NaCl film) n¢ (cm-1) 3385, 2933,
1620, 1580, 1503, 1452, 1366, 1234, 1198, 1161, 1125, 822. H
7-Phenyl-5H,12H-indolo[3,2-a]carbazole (6g). The title com-
pound 6g was prepared according to the typical procedure using
indole 9a (100 mg, 0.86 mmol) and b-nitrostyrene 8b. Purification
was carried out by flash chromatography (cyclohexane/ethyl
acetate 8 : 1) to afford 6g (76 mg, 53%) as a colorless solid. Mp:
230–232 ◦C (colorless prisms from ethyl acetate). IR (KBr) n¢
(cm-1) 3373, 3334, 3046, 2999, 2960, 2935, 1638, 1584, 1512, 1459,
1416, 1322, 1270, 1122, 1039, 836, 732. 1H NMR (CDCl3) d 7.05
(ddd, J = 7.9 Hz, J = 7.2 Hz, J = 1.0 Hz, 1H), 7.19 (s, 1H), 7.33–
7.44 (m, 3H), 7.49 (ddd, J = 7.4 Hz, J = 6.9 Hz, J = 1.0 Hz, 1H),
7.53–7.61 (m, 5H), 7.71 (dd, J = 8.0 Hz, J = 1.8 Hz, 1H), 8.21
(d, J = 7.7 Hz, 1H), 8.29 (br s, D2O exch., 1H, NH), 8.74 (br
s, D2O exch., 1H, NH). 13C NMR (CDCl3) d 105.2 (CH), 106.2
(Cq), 110.6 (CH), 110.8 (CH), 114.0 (Cq), 119.5 (CH), 119.9 (CH),
120.5 (CH), 121.4 (CH), 122.0 (Cq), 123.9 (Cq, CH), 124.6 (CH),
127.5 (CH), 128.4 (CH ¥ 2), 129.5 (CH ¥ 2), 134.4 (Cq), 136.5
(Cq ¥ 2), 138.8 (CH), 138.9 (Cq), 139.2 (Cq), 141.7 (Cq). MS
(ZQ2000/ESI+) m/z 355 [M+Na]+. HRMS (QTOF/ESI+) calcd
for C24H16N2Na ([M + Na]+), m/z 355.1211, found 355.1220.
1
NMR (acetone-d6) d 3.85 (OCH3), 3.86 (OCH3), 3.87 (s, 6H,
OCH3 ¥ 2), 3.91 (s, 3H, OCH3), 6.66 (dd, J = 8.8 Hz, J = 2.4
Hz, 1H), 6.93 (dd, J = 8.6 Hz, J = 2.3 Hz, 1H), 6.95 (s, 2H); 7.14
(d, J = 2.5 Hz, 1H), 7.15 (d, J = 2.5 Hz, 1H), 7.22 (s, 1H), 7.43 (d,
J = 8.7 Hz, 1H), 8.39 (d, J = 8.6 Hz, 1H), 10.44 (br s, D2O exch.,
1H, NH), 10.84 (br s, D2O exch., 1H, NH). 13C NMR (acetone-
d6) d 54.7 (OCH3), 54.9 (OCH3), 55.6 (OCH3 ¥ 2), 59.9 (OCH3),
94.7 (CH), 94.9 (CH), 104.6 (CH), 106.8 (CH ¥ 2), 107.2 (CH),
108.0 (CH), 113.3 (Cq), 115.7 (Cq), 117.6 (Cq), 121.3 (CH), 121.6
(CH), 133.8 (Cq), 133.9 (Cq), 137.6 (Cq), 137.7 (Cq), 138.8 (Cq),
141.0 (Cq), 141.2 (Cq), 153.4 (Cq ¥ 2), 157.6 (Cq), 158.3 (Cq). MS
(ZQ2000/ES+) m/z 505 [M + Na]+. HRMS (QTOF/ESI+) calcd
for C29H26N2O5Na, m/z 505.1739, found 505.1737.
3,10-Dibromo-2,9-dimethoxy-7-(3¢,4¢,5¢-trimethoxyphenyl)-5H,
12H-indolo[3,2-a]carbazole (6e). The title compound 6e was pre-
pared according to the typical procedure using indole 9f (100 mg,
0.44 mmol) and b-nitrostyrene 8a. Purification was carried-out by
flash chromatography (cyclohexane/ethyl acetate 7 : 3) to afford 6e
(93 mg, 66%) as a colorless solid. Mp: 142–144 ◦C (from acetone).
IR (NaCl film) n¢ (cm-1) 2924, 1592, 1560, 1508, 1459, 1425, 1381,
1359, 1322, 1237, 1205, 1158, 1127, 999. 1H NMR (DMSO-d6) d
3.58 (OCH3), 3.77 (OCH3), 3.82 (s, 6H, OCH3 ¥ 2), 4.08 (s, 3H,
OCH3), 6.88 (s, 1H), 6.91 (s, 2H), 7.22 (s, 1H), 7.79 (s, 1H), 7.80
(s, 1H), 8.29 (s, 1H), 11.52 (br s, D2O exch., 1H, NH), 11.91 (br s,
D2O exch., 1H, NH). 13C NMR (DMSO-d6) d 56.2 (OCH3), 56.5
(OCH3 ¥ 2), 57.7 (OCH3), 60.6 (OCH3), 104.0, 104.9, 105.4, 105.9,
106.9 (CH ¥ 2), 107.1, 108.6, 112.3, 115.1 (CH), 115.3 (CH), 121.4,
123.5 (CH/q), 134.6 (Cq), 134.9 (Cq), 135.0 (Cq), 136.2 (Cq),
136.9 (Cq), 137.4 (Cq), 140.4 (Cq), 148.9 (Cq), 149.8 (Cq), 153.3
(Cq ¥ 2). MS (ZQ2000/ESI+) m/z 665 [C29H2481Br2N2O5Na]+,
663 [C29H2479Br81BrN2O5Na]+, 661 [C29H2479Br2N2O5Na]+. HRMS
(QTOF/ESI+) calcd for C29H2479Br81Br N2O5Na, m/z 662.9929,
found 662.9925.
7-(4¢-Methyl)-5H,12H-indolo[3,2-a]carbazole (6h). The title
compound 6h was prepared according to the typical procedure
using indole 9a (50 mg, 0.43 mmol) and b-nitrostyrene 8c. Purifica-
tion was carried out by flash chromatography (cyclohexane/ethyl
acetate 9◦: 1) to afford 6h (23 mg, 31%) as a colorless solid. Mp:
256–258 C (from acetone). IR (KBr) n¢ (cm-1) 3461, 3378, 3016,
2916, 1637, 1611, 1758, 1518, 1455, 1374, 1353, 1263, 1180, 1155,
1
1020, 821, 802, 747. H NMR (acetone-d6) d 2.50 (s, 3H, CH3),
6.96 (ddd, J = 7.5 Hz, J = 1.1 Hz, 1H), 7.25 (s, 1H), 7.31 (ddd,
J = 7.5 Hz, J = 1.1 Hz, 2H), 7.38–7.47 (m, 4H), 7.58 (d, J = 9.0
Hz, 2H), 7.63 (dd, J = 9.0 Hz, J = 3.0 Hz, 2H), 8.57 (dd, J = 9.0
Hz, J = 3.0 Hz, 1H, H1), 10.65 (br s, D2O exch., 1H, NH), 11.04
(br s, D2O exch., 1H, NH). 13C NMR (acetone-d6) d 20.5 (CH3),
105.0 (CH), 106.0 (Cq), 110.8 (CH), 110.9 (CH), 113.2 (Cq), 118.7
(CH), 119.1 (CH), 120.7 (CH), 120.8 (CH), 121.9 (Cq), 123.3
(CH), 123.9 (Cq), 124.2 (CH), 128.9 (CH ¥ 2), 129.2 (CH ¥ 2),
134.6 (Cq), 136.2 (Cq), 136.9 (Cq), 139.3 (Cq), 139.5 (Cq ¥ 2),
139.9 (Cq). MS (ZQ2000/ESI+) m/z 369 [M + Na]+, 347 [M +
H]+. HRMS (QTOF/ESI+) calcd for C25H19N2 ([M + H]+), m/z
347.1524, found 347.1531.
2,9-Dibromo-7-(3¢,4¢,5¢-trimethoxyphenyl)-5H,12H-indolo[3,2-
a]carbazole (6f). The title compound 6f was prepared according
to the typical procedure using indole 9g (100 mg, 0.86 mmol)
and b-nitrostyrene 8a. Purification was carried out by flash
chromatography (cyclohexane/ethyl acetate 8 : 2) to afford 6f
7-(4¢-Methoxyphenyl)-5H,12H-indolo[3,2-a]carbazole
(6i).
◦
(26 mg, 18%) as a colorless solid. Mp: >350 C (from acetone).
The title compound 6i was prepared according to the typical
procedure using indole 9a (50 mg, 0.43 mmol) and b-nitrostyrene
8d. Purification was carried out by flash chromatography
(cyclohexane/dichloromethane 7 : 3) to afford 6i (31 mg, 40%) as
a colorless solid. Mp: 314–316 ◦C (from dichloromethane/acetone
9 : 1). IR (KBr) n¢ (cm-1) 3417, 3011, 2918, 1708, 1642, 1607, 1516,
1456, 1378, 1321, 1285, 1266, 1182, 1149, 1126, 1023, 841, 819,
IR (KBr) n¢ (cm-1) 3442, 3384, 2999, 2960, 2933, 2834, 1638,
1577, 1509, 1457, 1413, 1372, 1368, 1310, 1284, 1235, 1121, 1083,
1053, 1003, 901, 850, 797, 760, 736, 685, 658, 571, 434. 1H NMR
(acetone-d6) d 3.89 (s, 3H, OCH3), 3.92 (s, 6H, OCH3 ¥ 2), 6.99
(s, 2H), 7.37 (s, 1H), 7.43 (dd, J = 8.5 Hz, J = 2.0 Hz, 1H), 7.56
(dd, J = 8.6 Hz, J = 1.8 Hz, 1H), 7.59–7.66 (m, 2H), 7.70 (d, J =
2.0 Hz, 1H), 8.70 (d, J = 1.8 Hz, 1H), 10.96 (br s, D2O exch., 1H,
NH), 11.38 (br s, D2O exch., 1H, NH). 13C NMR (acetone-d6) d
55.7 (OCH3 ¥ 2), 59.9 (OCH3), 105.5 (CH), 106.8 (CH ¥ 2), 111.3
(Cq), 111.7 (Cq), 112.4 (Cq), 112.7 (CH ¥ 2), 123.1 (CH), 123.4
(Cq), 123.5 (CH), 125.5 (Cq), 126.0 (CH), 127.0 (CH), 134.9 (Cq),
136.6 (Cq), 137.1 (Cq), 138.2 (Cq), 138.6 (Cq), 140.3 (Cq), 153.6
(Cq ¥ 2). MS (ZQ2000/ES+) m/z 605 [C27H2081Br2N2O3Na]+,
603 [C27H2079Br81BrN2O3Na]+, 601 [C27H2079Br2N2O3Na]+. HRMS
(QTOF/ESI+) calcd for C27H20Br2N2O3Na, m/z 602.9718, found
602.9706.
1
749, 734. H NMR (acetone-d6) d 3.98 (s, 3H, OCH3), 6.97 (dd,
J = 7.5 Hz, 1H), 7.16 (d, J = 8.6 Hz, 1H) 7.24 (s, 1H), 7.25–7.33
(m, 2H), 7.40–7.46 (m, 2H), 7.60–7.65 (m, 4H), 8.56 (d, J = 7.7
Hz, 1H), 10.65 (br s, D2O exch., 1H, NH), 11.01 (br s, D2O exch.,
1H, NH). 13C NMR (acetone-d6, 75 MHz) d 54,7 (OCH3), 105.0
(CH), 105.9 (Cq), 110.7 (CH), 110.8 (CH), 113.3 (Cq), 113.7
(CH ¥ 2), 118.7 (CH), 119.1 (CH), 120.7 (CH), 120.8 (CH),
121.9 (Cq), 123.2 (CH), 123.9 (Cq), 124.1 (CH), 130.4 (CH ¥ 2),
134.4 (Cq), 134.5 (Cq), 135.9 (Cq), 139.4 (Cq), 139.5 (Cq), 139.9
(Cq), 159.3 (Cq). MS (ZQ2000/ESI-) m/z 361 [M - H]-. HRMS
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 7780–7790 | 7787
©